0001860010-22-000002.txt : 20220301 0001860010-22-000002.hdr.sgml : 20220301 20220301212258 ACCESSION NUMBER: 0001860010-22-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220228 FILED AS OF DATE: 20220301 DATE AS OF CHANGE: 20220301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ORTH ANDREW C. CENTRAL INDEX KEY: 0001860010 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38210 FILM NUMBER: 22701020 MAIL ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Krystal Biotech, Inc. CENTRAL INDEX KEY: 0001711279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 821080209 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: (412) 586-5830 MAIL ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 4 1 wf-form4_164618775853736.xml FORM 4 X0306 4 2022-02-28 0 0001711279 Krystal Biotech, Inc. KRYS 0001860010 ORTH ANDREW C. C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 15203 0 1 0 0 Chief Commercial Officer Common Stock 100 D Stock Option (Right to Buy) 63.55 2022-02-28 4 A 0 50000 0 A 2032-02-28 Common Stock 50000.0 50000 D The option vests in four equal annual installments beginning on February 28, 2023. /s/ Andrew Orth 2022-03-01